A9699 HCPCS code: Radiopharmaceutical, therapeutic, not otherwise classified
A9699 is the HCPCS Level II code for radiopharmaceutical, therapeutic, not otherwise classified. In 2022 Medicare paid an average of $9,609.70 per service for A9699 across 1,278 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. In 2022, about 61 clinicians billed Medicare for A9699 for 214 beneficiaries; Georgia, Texas, Nebraska accounted for 81% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2003-01-01 |
| Last action effective | 2006-01-01 |
Who bills A9699 (2022)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 61 |
| Medicare beneficiaries | 214 |
| States with claims | 9 |
| Share of services in top 3 states (Georgia, Texas, Nebraska) | 81% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9699, 2022–2022
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,278 | 214 | $12,058.34 | $9,609.70 |
States with the most A9699 services (2022)
| State | Services | Avg. paid |
|---|---|---|
| Georgia | 578 | $2,658.24 |
| Texas | 44 | $37,977.86 |
| Nebraska | 37 | $33,356.76 |
| Virginia | 32 | $35,760.26 |
| Arkansas | 27 | $36,760.72 |
Medicare policy articles for this code
- A54880: Billing and Coding: Additional Claim Documentation Requirements for Not Otherwise Classified (NOC) Drugs and Biological Products with Specific FDA Label Indications (Palmetto GBA (MAC - Part A, MAC - Part B))
What changed for A9699
- 2003-01-01: A9699 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9699?
A9699 is the HCPCS Level II code for radiopharmaceutical, therapeutic, not otherwise classified. Short descriptor: "Radiopharm rx agent noc".
How much does Medicare pay for A9699?
In 2022, the average Medicare payment was $9,609.70 per service (average allowed $12,058.34).
Does Medicare cover A9699?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related A96 codes
- A9600 — Strontium sr-89 chloride, therapeutic, per millicurie
- A9601 — Flortaucipir f 18 injection, diagnostic, 1 millicurie
- A9602 — Fluorodopa f-18, diagnostic, per millicurie
- A9603 — Injection, pafolacianine, 0.1 mg
- A9604 — Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries
- A9606 — Radium ra-223 dichloride, therapeutic, per microcurie
- A9607 — Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie
- A9608 — Flotufolastat f 18, diagnostic, 1 millicurie
- A9609 — Fludeoxyglucose f18 up to 15 millicuries
- A9610 — Xenon xe-129 hyperpolarized gas, diagnostic, per study dose
- A9611 — Flurpiridaz f 18, diagnostic, 1 millicurie
- A9612 — Injection, fluorescein, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9699
- Watch A9699 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9699
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.